RASIONALITAS PENGGUNAAN OBAT ANTIHIPERTENSI PADA PASIEN HIPERTENSI RAWAT INAP DI RS DAERAH Dr. A. DADI TJOKRODIPO BANDAR LAMPUNG
DOI:
https://doi.org/10.37090/jfl.v9i1.329Abstract
Abstract
Hypertension is one of non contagious diseases marked by the increase of systolic blood pressure > 140 mmHg and diastolic blood pressure > 90 mmHg. Hypertension becomes the main risk factor of other cardiovascular diseases. The number of hypertension occurance with or without companion increases every year. The purpose of this research is to know the rationality of anti - hypertension medicine usage on hypertension inpatients at RSUD of Dr. A. Dadi Tjokrodipo Bandar Lampung year of 2019 based on precise patient, precise indication, precise medicine, and precise dosage using reference standard of Guidelines JNCVIII. This research was a descriptive research with data collection of medical record retrospectively. The technique of sample selection used purposive sampling technique. The research results obtained from 82 samples based on the patients’ characteristics of genders such as 50 female patients (60,98%) and 42 male patients (39,02%). The patients’ characteristics based on age obtain mostly the patients are at age of 46-55 years old in the amount of 39 patients (47,6%). The patients’ characteristics based on the pattern of medicine usage obtain the most anti-hypertension used is amlodipin CCB class in the amount of 54 patients (45%). Rationality evaluation of anti-hypertension medicine usage obtains precise patient in the amount of 81 patients (99,8%), precise indication in the amount of 82 patients (100%), precise medicine in the amount of 61 patients (74,4%), and precise dosage in the amount of 82 patients (100%). The conclusion of this research is the usage of hypertension on the hypertension inpatients at Public Hospital of Dr. A. Dadi Tjokrodipo Bandar Lampung is already rational.
Keywords: Anti-hypertension, Hypertension, Rationality of Medicine Usage
References
Daftar Pustaka
Ansar J, Dwinata I MA. Determinan Kejadian Hipertensi Pada Pengunjung Posbindu Di Wilayah Kerja Puskesmas Ballaparang Kota Makassar. J Nas Ilmu Kesehat. 2019.
Kementrian Kesehatan Republik Indonesia (Kemenkes RI). Hipertensi penyebab kematian nomor tiga. Pus Komun Publik, Sekr Jenderal Kementeri Kesehatan. 2010.
Riset Kesehatan Dasar (RISKESDAS). laporan Nasional. Badan Penelitian dan Pengembangan Kesehatan Riset. 2018.
Tirtasari S, Kodim N. Prevalensi dan karakteristik hipertensi pada usia dewasa muda di Indonesia. Tarumanagara Med J. 2019.
Triyanto E. Pelayanan Keperawatan bagi penderita Hipertensi Secara Terpadu. J Kesehat Med SANTIKA. 2014.
Kemenkes RI. Modul Penggunaan Obat Rasional. kemenkes RI. 2011.
Erene Nanda Lyswanti Suyono. Studi Pengguna Obat Antihipertensi Pada Penderita Hipertens Rawat Inap. 2005;113.
WHO. Adherence to long-term therapies: Evidence for action. World Health Organization. Eur J Cardiovasc Nurs. 2012.
Pedoman Teknis dan Tata Laksana Penyakit Hipertensi, Direktorat Pengendalian Penyakit Tidak Menular Direktorat Jendral PP & PL Departemen Kesehatan RI Tahun 2010.
American Heart Association. classes oh heart failure. 2011.
Farmakope Indonesia Edisi III. Departemen Kesehatan Republik Indonesia, Jakarta. Tahun 1979.
Sumawa PMR, Wullur AC, Yamlean PVY. Evaluasi Kerasionalan Penggunaan Obat Antihipertensi Pada Pasien Hipertensi Rawat Inap Di Rsup Prof. Dr. R. D. Kandou Manado Periode Januari-Juni 2014. PHARMACONJurnal Ilm Farm – UNSRAT. 2015.
Muhadi. JNC 8 : Evidence-based Guideline Penanganan Pasien Hipertensi Dewasa. Cermin Dunia Kedokt. 2014.
